PubRank

G M Kostner

Author PubWeight™ 146.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. EMBO J 1999 1.72
2 The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions. FEBS Lett 1979 1.70
3 Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 1981 1.54
4 Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I. Biochim Biophys Acta 1986 1.53
5 Turnover of lipoprotein (a) in man. J Clin Invest 1980 1.48
6 Adenovirus-mediated rescue of lipoprotein lipase-deficient mice. Lipolysis of triglyceride-rich lipoproteins is essential for high density lipoprotein maturation in mice. J Biol Chem 2001 1.43
7 Postprandial hyperlipemia inhibits platelet aggregation without affecting prostanoid metabolism. Prostaglandins Leukot Essent Fatty Acids 1989 1.42
8 Investigations on beta 2-glycoprotein-I in the rat: isolation from serum and demonstration in lipoprotein density fractions. Int J Biochem 1980 1.38
9 A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32. Am J Hum Genet 1999 1.34
10 Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood 2001 1.30
11 Submaximal stimulation of porcine endothelial cells causes focal Ca2+ elevation beneath the cell membrane. J Physiol 1998 1.29
12 Correlation of hormones with lipid and lipoprotein levels during normal pregnancy and postpartum. J Clin Endocrinol Metab 1987 1.24
13 Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man. J Clin Invest 1983 1.22
14 Serum concentrations of Lp(a) and other lipoprotein parameters in heavy alcohol consumers. Ann Nutr Metab 1982 1.22
15 Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation. Atherosclerosis 1987 1.18
16 Apolipoprotein E e4 allele in the normal elderly: neuropsychologic and brain MRI correlates. Clin Genet 1996 1.17
17 Anandamide-induced mobilization of cytosolic Ca2+ in endothelial cells. Br J Pharmacol 1999 1.14
18 Lipoprotein Lp(a). A risk factor for myocardial infarction. Arteriosclerosis 1988 1.14
19 Plasma lipids and lipoproteins of a patient with cholesteryl ester storage disease. J Inherit Metab Dis 1985 1.12
20 Letter: Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanion precipitation. Clin Chem 1976 1.12
21 Determination of high-density lipoproteins: screening methods compared. Clin Chem 1979 1.12
22 Polypeptide distribution of the main lipoprotein density classes separated from human plasma by rate zonal ultracentrifugation. Eur J Biochem 1974 1.09
23 Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: relationship to peroxides and vitamin-E. Breast Cancer Res Treat 1995 1.09
24 Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin. Clin Chem 1989 1.05
25 High D-glucose-induced changes in endothelial Ca2+/EDRF signaling are due to generation of superoxide anions. Diabetes 1996 1.03
26 Isolation of subfractions of human very low density lipoproteins by zonal ultracentrifugation. J Biol Chem 1978 1.01
27 Apolipoprotein E polymorphism is not associated with longevity or disability in a sample of Italian octo- and nonagenarians. Gerontology 1998 1.01
28 Activation of microsomal cytochrome P450 mono-oxygenase by Ca2+ store depletion and its contribution to Ca2+ entry in porcine aortic endothelial cells. Br J Pharmacol 1997 1.01
29 Determination of fatty acids in the main lipoprotein classes by capillary gas chromatography: BF3/methanol transesterification of lyophilized samples instead of Folch extraction gives higher yields. Anal Biochem 1991 1.00
30 Muscle-specific overexpression of lipoprotein lipase in transgenic mice results in increased alpha-tocopherol levels in skeletal muscle. Biochem J 1996 0.99
31 Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta. Arteriosclerosis 1989 0.99
32 Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem 1986 0.99
33 Structure of the cholesteryl ester core of human plasma low density lipoproteins: selective deuteration and neutron small-angle scattering. Proc Natl Acad Sci U S A 1984 0.96
34 LDLR Database (second edition): new additions to the database and the software, and results of the first molecular analysis. Nucleic Acids Res 1998 0.96
35 Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution. Diabetes 1999 0.96
36 Effects of low- and high-density lipoproteins on the proliferation of human breast cancer cells in vitro: differences between hormone-dependent and hormone-independent cell lines. Int J Cancer 1989 0.95
37 Lipoprotein-associated alpha-tocopheryl-succinate inhibits cell growth and induces apoptosis in human MCF-7 and HBL-100 breast cancer cells. Biochim Biophys Acta 2000 0.95
38 Sulfhydryl-selective fluorescence labeling of lipoprotein(a) reveals evidence for one single disulfide linkage between apoproteins(a) and B-100. Biochemistry 1991 0.93
39 Human paraoxonase 1 gene polymorphisms and the risk of coronary heart disease: a community-based study. Cardiology 2002 0.93
40 Angiotensinogen gene promoter haplotype and microangiopathy-related cerebral damage: results of the Austrian Stroke Prevention Study. Stroke 2001 0.92
41 International Federation of Clinical Chemistry standardization project for the measurement of lipoprotein(a). Phase I. Evaluation of the analytical performance of lipoprotein(a) assay systems and commercial calibrators. Clin Chem 1998 0.91
42 Platelet activation in normo- and hyperlipoproteinemias. Basic Res Cardiol 1987 0.91
43 Characterization of isoelectric subspecies of asialo-beta 2-glycoprotein I. Biochem J 1989 0.91
44 Alterations in platelet Ca2+ signalling in diabetic patients is due to increased formation of superoxide anions and reduced nitric oxide production. Diabetologia 1999 0.90
45 Apo(a)-kringle IV-type 6: expression in Escherichia coli, purification and in vitro refolding. Protein Eng 2000 0.90
46 Intracellular mechanism of high D-glucose-induced modulation of vascular cell proliferation. Eur J Pharmacol 1995 0.90
47 Increased selective uptake in vivo and in vitro of oxidized cholesteryl esters from high-density lipoprotein by rat liver parenchymal cells. Biochem J 1996 0.89
48 Activation of lecithin-cholesterol acyltransferase by apolipoprotein D: comparison of proteoliposomes containing apolipoprotein D, A-I or C-I. Biochim Biophys Acta 1988 0.89
49 Interaction of beta 2-glycoprotein-I with human blood platelets: influence upon the ADP-induced aggregation. Thromb Haemost 1985 0.89
50 Preparation of 18O-labelled standards of hydroxy-eicosatetraenoic acids and thromboxanes for quantitative measurement by gas chromatography/mass spectrometry. Biomed Environ Mass Spectrom 1986 0.88
51 Enhanced association of platelet-activating factor acetylhydrolase with lipoprotein (a) in comparison with low density lipoprotein. J Biol Chem 1995 0.88
52 Beta-fibrinogen gene polymorphism (C148-->T) is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study. Arterioscler Thromb Vasc Biol 1998 0.88
53 Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. Stroke 1997 0.88
54 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Standardization Project for the Measurement of Lipoprotein(a). Phase 2: selection and properties of a proposed secondary reference material for lipoprotein(a). Clin Chem Lab Med 1999 0.88
55 Neutron small angle scattering on selectively deuterated human plasma low density lipoproteins. The location of polar phospholipid headgroups. J Biol Chem 1981 0.88
56 Quantitative measurement of 5-, 12-, and 15-hydroxyeicosatetraenoic acid together with 12-hydroxyheptadecatrienoic acid by stable isotope dilution gas chromatography-negative ion chemical ionization-mass spectrometry. Anal Biochem 1987 0.87
57 Mechanism of the interaction of beta(2)-glycoprotein I with negatively charged phospholipid membranes. Biochemistry 2001 0.87
58 Effects of superoxide anions on endothelial Ca2+ signaling pathways. Arterioscler Thromb Vasc Biol 1998 0.87
59 Serum lipids and lipoproteins in patients with primary gout. Rheumatol Int 1985 0.86
60 Lipoprotein binding to cultured human hepatoma cells. J Clin Invest 1987 0.86
61 Lipoprotein lipase mediates the uptake of glycated LDL in fibroblasts, endothelial cells, and macrophages. Diabetes 2001 0.86
62 Low-density lipoprotein receptor mRNA in human breast cancer cells: influence by PKC modulators. Breast Cancer Res Treat 1997 0.86
63 Fluctuations of plasma lipoprotein-A concentrations during pregnancy and post partum. Metabolism 1986 0.86
64 Studies on the composition of pig serum lipoproteins. Isolation and characterization of different apoproteins. Biochim Biophys Acta 1975 0.86
65 Oxidation of lipoprotein Lp(a). A comparison with low-density lipoproteins. Biochim Biophys Acta 1991 0.86
66 The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma. J Clin Invest 1994 0.86
67 Identification of glycoprotein IIb as the lipoprotein(a)-binding protein on platelets. Lipoprotein(a) binding is independent of an arginyl-glycyl-aspartate tripeptide located in apolipoprotein(a). Arterioscler Thromb 1994 0.85
68 Increased superoxide anion formation in endothelial cells during hyperglycemia: an adaptive response or initial step of vascular dysfunction? Diabetes Res Clin Pract 1999 0.84
69 Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study. Stroke 1998 0.84
70 Comparison of effects of N-3 to N-6 fatty acids on serum level of lipoprotein(a) in patients with coronary artery disease. Am J Cardiol 1995 0.84
71 Lipoprotein (a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes. Blood 2001 0.84
72 Therapy of hyper-Lp(a). Handb Exp Pharmacol 2005 0.84
73 Isolation of pure LpB from human serum. J Lipid Res 1986 0.83
74 Apolipoproteins (A-I, A-II, B), Lp(a) lipoprotein and lecithin: cholesterol acyltransferase activity in diabetes mellitus. Atherosclerosis 1983 0.83
75 Lipoprotein (a) and plasminogen are immunochemically related. Biochim Biophys Acta 1988 0.83
76 Structural requirements of apo-a for the lipoprotein-a assembly. Biochem J 1994 0.83
77 Lipoprotein(a) in health and disease. Crit Rev Clin Lab Sci 1996 0.83
78 Angiotensinogen polymorphism M235T, carotid atherosclerosis, and small-vessel disease-related cerebral abnormalities. Hypertension 2001 0.83
79 Adenovirus-mediated apo(a)-antisense-RNA expression efficiently inhibits apo(a) synthesis in vitro and in vivo. Gene Ther 2001 0.83
80 Potentiation of Ca2+ signaling in endothelial cells by 11,12-epoxyeicosatrienoic acid. J Cardiovasc Pharmacol 1999 0.83
81 Apolipoproteins AI, AII and HDL phospholipids but not APO-B are risk indicators for occlusive cerebrovascular disease. Eur Neurol 1986 0.83
82 Role of superoxide anions in changes of endothelial vasoactive response during acute hyperglycemia. Horm Metab Res 1997 0.83
83 Mechanisms of L-NG nitroarginine/indomethacin-resistant relaxation in bovine and porcine coronary arteries. Br J Pharmacol 1996 0.83
84 Impact of apolipoprotein(a) on in vitro angiogenesis. Arterioscler Thromb Vasc Biol 2001 0.82
85 The role of lecithin:cholesterol acyltransferase for the low density lipoprotein composition and specific binding to the B receptor. Biochim Biophys Acta 1982 0.82
86 Investigation of the abnormal low-density lipoproteins occurring in patients with obstructive jaundice. Biochem J 1976 0.82
87 Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells. Diabetes 1999 0.82
88 Determination of lipoprotein(a): evaluation of three methods. Eur J Clin Chem Clin Biochem 1993 0.82
89 Risk factors for microangiopathy-related cerebral damage in the Austrian stroke prevention study. J Neurol Sci 1997 0.82
90 Organization of phosphatidylcholine and sphingomyelin in the surface monolayer of low density lipoprotein and lipoprotein(a) as determined by time-resolved fluorometry. J Biol Chem 1992 0.82
91 Cyclooxygenase and lipoxygenase metabolites during platelet aggregation: quantitative measurement by negative ion chemical ionization--gas chromatography/mass spectrometry. Prostaglandins Leukot Med 1987 0.82
92 Immunochemical measurement of lipoprotein-X. Clin Chem 1974 0.81
93 The interaction of human plasma low density lipoproteins with glycosamino-glycans: influence of the chemical composition. Lipids 1985 0.81
94 High-density lipoprotein antagonizes the inhibitory effects of oxidized low-density lipoprotein and lysolecithin on soluble guanylyl cyclase. Biochem Biophys Res Commun 1992 0.81
95 Inhibitors for the in vitro assembly of Lp(a). Arterioscler Thromb Vasc Biol 1995 0.81
96 Quantification of lipoprotein lipase (LPL) by dissociation-enhanced lanthanide fluorescence immunoassay. Comparison of immunoreactivity of LPL mass and enzyme activity of LPL. J Immunol Methods 1996 0.81
97 Urinary excretion of apo(a) fragments. Role in apo(a) catabolism. Arterioscler Thromb Vasc Biol 1996 0.81
98 Effect of tranexamic acid and delta-aminovaleric acid on lipoprotein(a) metabolism in transgenic mice. Biochim Biophys Acta 1999 0.81
99 MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms : three-year follow-up of the austrian stroke prevention study. Arterioscler Thromb Vasc Biol 2000 0.81
100 Expression of fat mobilizing genes in human epicardial adipose tissue. Atherosclerosis 2011 0.80
101 Preparation of fatty acid methyl esters from lipoprotein and macrophage lipid subclasses on thin-layer plates. Lipids 1996 0.80
102 High-level expression of various apolipoprotein(a) isoforms by "transferrinfection": the role of kringle IV sequences in the extracellular association with low-density lipoprotein. Biochemistry 1994 0.80
103 Thermotropic changes in the surface structure of lipoprotein B from human-plasma low-density lipoproteins. A spin-label study. Eur J Biochem 1978 0.80
104 Evaluation of a new HDL2/HDL3 quantitation method based on precipitation with polyethylene glycol. Clin Chim Acta 1985 0.80
105 High-density lipoprotein (HDL3)-associated alpha-tocopherol is taken up by HepG2 cells via the selective uptake pathway and resecreted with endogenously synthesized apo-lipoprotein B-rich lipoprotein particles. Biochem J 1998 0.80
106 Interaction of lipoprotein Lp[a] with the B/E-receptor: a study using isolated bovine adrenal cortex and human fibroblast receptors. J Lipid Res 1990 0.80
107 The in vitro formation of HDL2 during the action of LCAT: the role of triglyceride-rich lipoproteins. J Lipid Res 1985 0.80
108 Lysine modification of LDL or lipoprotein(a) by 4-hydroxynonenal or malondialdehyde decreases platelet serotonin secretion without affecting platelet aggregability and eicosanoid formation. Arterioscler Thromb Vasc Biol 1995 0.80
109 The separation of human serum high density lipoproteins by hydroxy apatite column chromatography. Evidence for the presence of discrete subfractions. Biochim Biophys Acta 1977 0.79
110 Lipoprotein Lp(a): impact on atherosclerosis and immunochemical quantification. Przegl Lek 1989 0.79
111 Cholesterol biosynthesis in dermal fibroblasts from patients with metabolic disorders of peroxisomal origin. Eur J Clin Invest 1995 0.79
112 Relationship between classic risk factors, plasma antioxidants and indicators of oxidant stress in angina pectoris (AP) in Tehran. Atherosclerosis 2000 0.79
113 Familial hypercholesterolemia in Austria reflects the multi-ethnic origin of our country. Atherosclerosis 2000 0.79
114 Binding of beta 2-glycoprotein-I to intralipid: determination of the dissociation constant. Biochem Biophys Res Commun 1979 0.79
115 In human hypercholesterolemia increased reactivity of vascular smooth muscle cells is due to altered subcellular Ca(2+) distribution. Atherosclerosis 2000 0.79
116 Photometric evaluation of lipid peroxidation products in human plasma and copper oxidized low density lipoproteins: correlation of different oxidation parameters. Atherosclerosis 1996 0.79
117 Vascular effects of L-arginine: anything beyond a substrate for the NO-synthase? Biochem Biophys Res Commun 1997 0.79
118 In vitro modification of the chemical composition of human plasma low density lipoproteins: effects of morphology and thermal properties. Chem Phys Lipids 1984 0.79
119 In vivo kinetics of lipoprotein(a) in homozygous Watanabe heritable hyperlipidaemic rabbits. Eur J Clin Invest 1993 0.79
120 A comparison of structure and thermal behavior in human plasma lipoprotein(a) and low-density lipoprotein. Calorimetry and small-angle X-ray scattering. Biochemistry 1995 0.79
121 Role of various tissues in apo(a) fragmentation and excretion of fragments by the kidney. Eur J Clin Invest 2001 0.79
122 Physiological and clinical importance of lipoprotein(a). Tokai J Exp Clin Med 1990 0.79
123 Quantification of apolipoprotein D by an immunoassay with time-resolved fluorescence spectroscopy. J Immunol Methods 1997 0.79
124 The assembly of lipoprotein Lp(a). Eur J Clin Invest 1996 0.79
125 Apolipoproteins and lipoproteins of human plasma: significance in health and in disease. Adv Lipid Res 1983 0.79
126 A novel missense mutation in the gene for lipoprotein lipase resulting in a highly conservative amino acid substitution (Asp180-->Glu) causes familial chylomicronemia (type I hyperlipoproteinemia). Genomics 1993 0.79
127 Action of lecithin-cholesterol acyltransferase on low-density lipoproteins in native pig plasma. Biochemistry 1987 0.78
128 Structural organization of free and esterified cholesterol in human high density lipoproteins. A 100.6 MHz 13C NMR study. Biochim Biophys Acta 1979 0.78
129 Quantification of 7-dehydrocholesterol in plasma and amniotic fluid by liquid chromatography/particle beam-mass spectrometry as a biochemical diagnostic marker for the Smith-Lemli-Opitz syndrome. Rapid Commun Mass Spectrom 1995 0.78
130 Implications of endogenous and exogenous lipoprotein lipase for the selective uptake of HDL3-associated cholesteryl esters by mouse peritoneal macrophages. J Lipid Res 1997 0.78
131 Oxidation of fluorescent glycero- and sphingophospholipids in human plasma lipoproteins: alkenylacyl subclasses are preferred targets. Clin Biochem 1996 0.78
132 The relative electrophoretic mobility of apo(a) isoforms depends on the gel system: proposal of a nomenclature for apo(a) phenotypes. Atherosclerosis 1996 0.78
133 Lipoprotein(a) inhibits collagen-induced aggregation of thrombocytes. Arterioscler Thromb Vasc Biol 1996 0.78
134 Urinary excretion of apolipoprotein(a): relation to other plasma proteins. Clin Chim Acta 2001 0.78
135 The determination of lecithin:cholesterol acyl transferase in the clinical laboratory: a modified enzymatic procedure. Clin Chim Acta 1980 0.78
136 The role of LCAT and cholesteryl ester transfer proteins for the HDL and LDL structure and metabolism. Adv Exp Med Biol 1987 0.78
137 Free and Apo B-associated Lpa-specific protein in human serum. Clin Chim Acta 1987 0.78
138 The low-density-lipoprotein pathway of native and chemically modified low-density lipoproteins isolated from plasma incubated in vitro. Biochem J 1984 0.78
139 Studies on the protein composition of human serum very low density lipoproteins: demonstration of the beta 2-glycoprotein-I. Hoppe Seylers Z Physiol Chem 1979 0.77
140 Transfer of phospholipase A-resistant pyrene-dialkyl-glycerophosphocholine to plasma lipoproteins: differences between Lp[a] and LDL. J Lipid Res 1995 0.77
141 Immunoquantification of total apolipoprotein B in serum by nephelometry: influence of lipase treatment and detergents. Clin Chem 1983 0.77
142 Oxidized low-density lipoprotein antagonizes the activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor but does not interfere with its biosynthesis. Cell Signal 1991 0.77
143 Activation of soluble guanylate cyclase by nitrovasodilators is inhibited by oxidized low-density lipoprotein. Biochem Biophys Res Commun 1990 0.77
144 Interaction of LDL, Lp[a], and reduced Lp[a] with monoclonal antibodies against apoB. J Lipid Res 1988 0.77
145 A comparative study of the localization of plasminogen and apolipoprotein(a) in human carcinomas. Thromb Res 1990 0.77
146 Molecular acoustic as a new tool for the study of biophysical properties of lipoproteins. Biophys Chem 1997 0.77
147 Influence of LDL oxidation on the proliferation of human breast cancer cells. Free Radic Biol Med 1996 0.77
148 The interaction of human apoB-containing lipoproteins with mouse peritoneal macrophages: a comparison of Lp(a) with LDL. J Lipid Res 1984 0.77
149 Lipid transfer protein-catalyzed exchange of cholesteryl ester between high density lipoproteins and apoB-containing lipoproteins. J Lipid Res 1987 0.77
150 Studies on the composition of the protein part of triglyceride rich lipoproteins of human serum: isolation of polymorphic forms of beta 2-glycoprotein-I. Artery 1981 0.77
151 Glycated low-density lipoprotein and atherogenesis: the missing link between diabetes mellitus and hypercholesterolaemia? Eur J Clin Invest 1997 0.77
152 [Lowering cholesterol 1998. Cholesterol synthesis inhibitors compared]. Wien Klin Wochenschr 1998 0.76
153 Methodological approaches for assessing lipid and protein oxidation and modification in plasma and isolated lipoproteins. Methods Mol Biol 1998 0.76
154 Endogenously produced glycosaminoglycans affecting the release of lipoprotein lipase from macrophages and the interaction with lipoproteins. Biochim Biophys Acta 2000 0.76
155 In vitro formation of HDL-2 from HDL-3 and triacylglycerol-rich lipoproteins by the action of lecithin:cholesterol acyltransferase and cholesterol ester transfer protein. Biochim Biophys Acta 1987 0.76
156 Total plasma apo E and high density lipoprotein apo E in survivors of myocardial infarction. Atherosclerosis 1984 0.76
157 Postprandial hyperlipemia and platelet eicosanoid metabolism. Klin Wochenschr 1990 0.76
158 Distribution and concentration of apolipoprotein E in high and low density lipoproteins. Ric Clin Lab 1984 0.76
159 Cholesterol metabolism in cells with different peroxisomal defects. Clin Chim Acta 1996 0.76
160 A novel assay for the quantitative determination of lipoprotein-X (LP-X) in serum. Clin Chim Acta 1983 0.76
161 Influence of beta 2-glycoprotein-I upon the content of cAMP and cGMP in human blood platelets. Thromb Haemost 1985 0.76
162 Antioxidants prevent high-D-glucose-enhanced endothelial Ca2+/cGMP response by scavenging superoxide anions. Eur J Pharmacol 1997 0.76
163 The determination of lipoprotein Lp(a) by rate and endpoint nephelometry. Clin Chim Acta 1983 0.76
164 A hyperalphalipoproteinaemic family with normal cholesteryl ester transfer/exchange activity. Biochem J 1987 0.75
165 LDL-mediated interaction of Lp[a] with HepG2 cells: a novel fluorescence microscopy approach. J Lipid Res 1997 0.75
166 The contribution of individual lipoproteins to the degradation of platelet-activating factor in human serum. Haemostasis 1989 0.75
167 Interaction of various lipoproteins from normal and dyslipoproteinemic plasma with mouse peritoneal macrophages. Ann Biol Clin (Paris) 1988 0.75
168 [Endogenous cholesterol synthesis]. Med Lab (Stuttg) 1978 0.75
169 The receptor-mediated endocytosis of lipoprotein (a). Z Gastroenterol 1996 0.75
170 The existence of B/E and E receptors on Hep-G2 cells: a study using colloidal gold- and 125I-labeled lipoproteins. Exp Mol Pathol 1987 0.75
171 Apoprotein-phospholipid interactions in Lp(a). Chem Phys Lipids 1994 0.75
172 [New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology]. Internist (Berl) 2014 0.75
173 Alpha-tocopherol and hydroperoxide content in breast adipose tissue from patients with breast tumors. Int J Cancer 1996 0.75
174 Is there any correlation between platelet aggregation, plasma lipoproteins, apoproteins and membrane fluidity of human blood platelets? Thromb Res 1989 0.75
175 Plasma concentrations of high-density lipoprotein (HDL)-2 and HDL-3 in myocardial infarction survivors and in control subjects. Clin Cardiol 1986 0.75
176 A new micromethod for routine measurement of serum LDL-apolipoprotein B. J Lipid Res 1988 0.75
177 Laboratory parameters as discriminators for peripheral atherosclerosis and stroke. Monogr Atheroscler 1986 0.75
178 Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics. Atherosclerosis 1982 0.75
179 LDL structure and Lp(a) formation: the role of lecithin:cholesterol acyltransferase. Z Gastroenterol 1996 0.75
180 Immunoturbidimetric determination of lipoprotein(a): improvement in the measurement of turbid and triglyceride-rich samples. Clin Chim Acta 1995 0.75
181 A double labeling procedure for lipoproteins: independent visualization of dual ligand-receptor interaction with colloidal gold- and 125I-labeled ligands. Anal Biochem 1995 0.75
182 Separation of subclasses of human serum high density lipoproteins by zonal ultracentrifugation. Prep Biochem 1977 0.75
183 The role of apo-(a) kringle-IVs in the assembly of lipoprotein-(a). Protein Eng 1997 0.75
184 Platelet membrane fluidity in type IIA, type IIB and type IV hyperlipoproteinemia. Atherosclerosis 1991 0.75
185 Immunoquantification of lipoprotein(a): comparison of nephelometry with electroimmunodiffusion. J Clin Lab Anal 1993 0.75
186 Lipoxygenases and hydroperoxy/hydroxy-eicosatetraenoic acid formation. Int J Biochem 1987 0.75
187 Current methods for apolipoprotein evaluation in normal and dyslipoproteinemic plasma. Ric Clin Lab 1982 0.75
188 Crystallization and preliminary X-ray crystallographic studies on apolipoprotein H (beta2-glycoprotein-I) from human plasma. Acta Crystallogr D Biol Crystallogr 1998 0.75
189 [HMA CoA reductase inhibitors]. Wien Med Wochenschr 1999 0.75
190 Fluorescence labeling and interaction of atherogenic lipoproteins with cultured cells. J Fluoresc 1994 0.75
191 [High density lipoproteins: the status quo (author's transl)]. Wien Klin Wochenschr 1980 0.75
192 Influence of dietary fish oils on plasma Lp(a) levels. Thromb Res 1990 0.75
193 [The role of apolipoproteins in lipid metabolism]. Ther Umsch 1990 0.75
194 [Immunologic correlations of Lp(a) lipoprotein and plasminogen]. Orv Hetil 1988 0.75
195 [Lipoproteins and atherosclerosis (importance of diet)]. Ric Clin Lab 1981 0.75
196 Apolipoproteins in diabetes mellitus. Monogr Atheroscler 1985 0.75
197 Influence of morphology and malignancy of three new human melanoma cell lines on the cyclooxygenase pathway. Prostaglandins 1989 0.75
198 The metabolism of human serum lipoproteins and their significance in medicine. Przegl Lek 1985 0.75
199 The influence of various lipoproteins and apolipoproteins on the in vitro esterification of cholesterol in human serum by the enzyme lecithin:cholesterol acyltransferase. Scand J Clin Lab Invest Suppl 1978 0.75
200 Urinary excretion of apo(a) fragments in NIDDM patients. Diabetologia 1997 0.75
201 Factors affecting the conversion of high-density lipoproteins: experiments with pig and human plasma. Biochim Biophys Acta 1985 0.75
202 A novel splice-site mutation in intron 7 causes more severe hypercholesterolemia than a combined FH-FDB defect. Atherosclerosis 2001 0.75
203 Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500-->Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins. J Biol Chem 1994 0.75
204 Apolipoproteins: significance for lipid metabolism and for diagnosis of atherosclerotic disease. Prog Clin Biol Res 1985 0.75
205 [Lipoprotein Lp(a) as a risk factor for heart infarct--a family study]. Wien Med Wochenschr 1984 0.75
206 A single G to A nucleotide transition in exon IV of the lecithin: cholesterol acyltransferase (LCAT) gene results in an Arg140 to His substitution and causes LCAT-deficiency. Hum Genet 1995 0.75
207 [Apolipoprotein analysis]. Med Lab (Stuttg) 1977 0.75
208 Biosynthesis of lipoprotein-a from transfected cells. Z Gastroenterol 1996 0.75
209 [Physiological significance of human apolipoproteins]. Acta Med Austriaca Suppl 1977 0.75
210 Standardization of Lp(a) assays. Clin Chim Acta 1992 0.75
211 Studies on the substrate specificity of human and pig lecithin: cholesterol acyltransferase: role of low-density lipoproteins. Biochemistry 1986 0.75
212 [Prevalence and risk factors in the population of Graz (Austrian Stroke Prevention Study)]. Wien Med Wochenschr 1997 0.75
213 Cholesterol esterification in mouse peritoneal macrophages in the presence of pathological human plasma lipoproteins. Biol Chem Hoppe Seyler 1986 0.75
214 Demonstration of receptor binding of two apo-B containing lipoproteins by differential labelling with colloidal gold. Eur J Cell Biol 1985 0.75
215 Effects of dietary fish oil supplementation on platelet aggregability and platelet membrane fluidity in normolipemic subjects with and without high plasma Lp(a) concentrations. Atherosclerosis 1991 0.75
216 Lp(a)--an atherogenic risk factor in human serum? Z Med Lab Diagn 1990 0.75
217 [A rheological study on plasma lipoproteins (author's transl)]. Hoppe Seylers Z Physiol Chem 1977 0.75
218 Interaction of fluorescent LDL and Lipoprotein (a) with HepG2 cells. Z Gastroenterol 1996 0.75
219 Transfer of pyrene-dietherphosphatidylcholine to serum lipoproteins. J Fluoresc 1994 0.75
220 Altered metabolism of low density lipoprotein in humans after prolonged incubation in plasma. Clin Sci (Lond) 1985 0.75
221 [Influence of fat or carbohydrate rich diet on the serum lipoprotein pattern of a child with primary hypertriglyceridemia (type V hyperlipoproteinemia according to Frederickson) (author's transl)]. Wien Klin Wochenschr 1974 0.75
222 [Hypercholesterolemia ]. Wien Med Wochenschr 1994 0.75
223 Genetic aspects of microangiopathy-related cerebral damage. J Neural Transm Suppl 2000 0.75
224 Effects of fish oils on lipid variables and platelet function indices. Prostaglandins Leukot Essent Fatty Acids 1993 0.75
225 Lecithin: cholesterol acyltransferase and its action on different substrates. Adv Exp Med Biol 1988 0.75
226 [Relationship of state of aggregation with various biochemical parameters--tested on platelet concentrates from buffy coats after 5 days of storage]. Beitr Infusionsther Transfusionsmed 1994 0.75
227 Isotope dilution gas chromatography-mass spectrometry for the study of eicosanoid metabolism in human blood platelets. J Chromatogr 1989 0.75
228 Measurement of arachidonic acid metabolites by gas chromatography/mass spectrometry during platelet aggregation. Prog Clin Biol Res 1987 0.75
229 [Evaluation of a newly discovered LDL receptor mutation (exon 10, GAC>AAC, D271N, "FH Graz-1") in familial hypercholesterolemia-- a familystudy]. Acta Med Austriaca 1999 0.75
230 Lipoprotein(a) plasma levels and apo(a) isoforms are not associated with longevity or disability in a sample of Italian octo-nonagenarians. Associazione Medica Sabin. Aging (Milano) 1995 0.75